Most people use substances of some kind at some point in their lives, whether it’s alcohol at a celebration, prescription ...

Substance-related disorders are common, affecting 40.3 million people over the age of 12 in the United States. Addiction may involve the use of prescribed drugs, such as opioid painkillers, common ...

Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...

Substance use and abuse has long been a concern for the nation, both in and out of the workplace (IOM, 1994), with consequences that include lost productivity, disease, and premature death. Indeed, it ...

When a person has both a mental illness and a substance use disorder, it is called co-occurring disorders. These health problems often affect each other, making it complicated to diagnose, treat, and ...

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

Substance use disorders (SUDs) in oncology populations represent a significant yet underrecognized challenge, with prior research suggesting that up to 27 percent of cancer patients meet criteria for ...

Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences—not from genes that ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

Discussions around Medicaid costs have become more heated than ever in recent months as President Donald Trump's administration tries to push its budget bill through the legislative ranks. House ...